Beauty

Kenvue Beats First-Quarter Estimates Amid Pending Acquisition by Kimberly-Clark

Tylenol-maker Kenvue on Thursday beat Wall Street estimates for first-quarter revenue and profit helped by strong sales in its ​skin health and beauty brands.

Related posts

Let’s Get Physical: Getting to Grips with Demna’s New Gucci

Raven Ward

Saks Global Obtains Court Approval for $400 Million in Rescue Financing

Raven Ward

The Face Magazine to Shutter

Raven Ward